Staphylococcus aureus Evasion of Host Immunity in the Setting of Prosthetic Joint Infection: Biofilm and Beyond
- PMID: 29987645
- PMCID: PMC6105484
- DOI: 10.1007/s12178-018-9501-4
Staphylococcus aureus Evasion of Host Immunity in the Setting of Prosthetic Joint Infection: Biofilm and Beyond
Abstract
Purpose of review: The incidence of complications from prosthetic joint infection (PJI) is increasing, and treatment failure remains high. We review the current literature with a focus on Staphylococcus aureus pathogenesis and biofilm, as well as treatment challenges, and novel therapeutic strategies.
Recent findings: S. aureus biofilm creates a favorable environment that increases antibiotic resistance, impairs host immunity, and increases tolerance to nutritional deprivation. Secreted proteins from bacterial cells within the biofilm and the quorum-sensing agr system contribute to immune evasion. Additional immunoevasive properties of S. aureus include the formation of staphylococcal abscess communities (SACs) and canalicular invasion. Novel approaches to target biofilm and increase resistance to implant colonization include novel antibiotic therapy, immunotherapy, and local implant treatments. Challenges remain given the diverse mechanisms developed by S. aureus to alter the host immune responses. Further understanding of these processes should provide novel therapeutic mechanisms to enhance eradication after PJI.
Keywords: Biofilm; Prosthetic joint infection; Staphylococcus aureus.
Conflict of interest statement
Conflict of Interest
Edward M Schwarz reports grants from NIH and AOTrauma during the conduct of the study and personal fees and other from Telephus, LLC, outside the submitted work. In addition, Dr. Schwarz has a patent on passive immunization and diagnostics for
The other authors declare that they have no conflicts of interest.
EMS has patents related to this work. EMS has received financial compensation and stock from Telephus Medical LLC.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Grant Sponsors
National Institutes of Health (EMS), Grant Numbers P30 AR069655 and P50 AR07200 (EMS), and AOTrauma Clinical Priority Program (EMS).
References
-
- Bryan AJ, Abdel MP, Sanders TL, Fitzgerald SF, Hanssen AD, Berry DJ. Irrigation and debridement with component retention for acute infection after hip arthroplasty: improved results with contemporary management. J Bone Joint Surg Am. 2017;99(23):2011–2018. - PubMed
-
- Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, Sánchez-Somolinos M, Baraia-Etxaburu JM, Rico A, Palomino J, Rodríguez-Pardo D, Horcajada JP, Benito N, Bahamonde A, Granados A, del Toro MD, Cobo J, Riera M, Ramos A, Jover-Sáenz A, Ariza J, REIPI Group for the Study of Prosthetic Infection A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis. 2013;56(2):182–194. - PubMed
-
- Nodzo SR, Boyle KK, Spiro S, Nocon AA, Miller AO, Westrich GH. Success rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infection. Knee. 2017;24(5):1175–1181. - PubMed
-
- Kaplan SL. Recent lessons for the management of bone and joint infections. J Inf Secur. 2014;68(Suppl 1):S51–S56. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
